Several of the TWEAK/Fn14-activated transcription factors (TFs) such as NF-κB2/p52 and AP-1 can bind accessible chromatin regions to modulate the genomic landscape of cancers and drive aberrant transcription36,46–48. This evidence concerns the gene JUN and cancer.